News Daily News Making Sense of Masters Athletes’ Cardiac Imaging: Expert Review Michael O'Riordan December 11, 2025
News Daily News Frail Patients Stand to Gain Most From Cardiac Rehab Michael O'Riordan November 26, 2025
News Daily News Revascularization Decisions in the Elderly Require a Holistic Approach: AHA Caitlin E. Cox November 24, 2025
News Daily News Risk Calculators Miss Many Patients Who Present With First MI Michael O'Riordan November 21, 2025
News Daily News High Adolescent BP Tied to Subclinical Disease in Middle Age Michael O'Riordan November 20, 2025
News Daily News PREVENT-TAHA8: Post-MI Intracoronary Stem Cells May Lower HF Risk After STEMI L.A. McKeown November 04, 2025
News Daily News Disparities in MCS Use for STEMI-Related Shock Seen Across the US Caitlin E. Cox October 21, 2025
News Daily News Type 2 MI Diagnoses on the Rise, but Best Course of Action Unknown Caitlin E. Cox October 08, 2025
News Daily News Novel Biomarker GDF-15 Helps Risk-Stratify Patients With Suspected ACS Todd Neale October 03, 2025
News Daily News Risk Factors Present in Nearly All Patients Who Develop CVD Michael O'Riordan October 02, 2025
News Daily News Recognize and Enable Care for Post-MI Psychological Distress: AHA L.A. McKeown October 01, 2025
News Daily News Lactate Clearance May Act as ‘Early Warning Sign’ in Cardiogenic Shock L.A. McKeown September 25, 2025
News Daily News CVD Still the Leading Cause of Death and Disease Globally Michael O'Riordan September 24, 2025
News Daily News CELEBRATE: Prehospital Platelet Inhibitor Zalunfiban Hits Mark in STEMI Michael O'Riordan September 23, 2025
News Daily News Better Outcomes and Lower Cost with Bariatric Surgery Over GLP-1s Michael O'Riordan September 18, 2025
News Daily News Nonatherosclerotic Causes of MI Common in Younger Patients L.A. McKeown September 17, 2025
News Daily News For Monotherapy, P2Y12 Inhibitor Bests Aspirin After PCI for ACS: Meta-analysis Yael L. Maxwell August 14, 2025
News Daily News Tirzepatide Matches Dulaglutide in Large CV Outcomes Trial: SURPASS-CVOT Michael O'Riordan July 31, 2025